McDonald's Stock Drops - Wall Street blames GLP-1 Meds [CBS News]
- Jun 15, 2025
- 2 min read
There’s never been a more exciting time to be part of our clinic’s GLP-1 program.
Not only are medications like Semaglutide and Tirzepatide helping our patients achieve meaningful, sustainable weight loss—they’re making such a big impact that even America’s largest fast food chains and Wall Street analysts are taking notice.
This week, McDonald’s stock price dropped after a major financial firm downgraded the company, citing the growing influence of GLP-1 weight loss medications like Semaglutide, and Tirzepatide. Analysts now believe that as more Americans embrace these appetite-suppressing treatments, fast food giants could lose millions of customer visits and hundreds of millions in revenue each year. In fact, McDonald’s could see up to $482 million in lost annual revenue, as people on GLP-1s are choosing to eat less fast food and make healthier choices at home instead.
What’s driving this shift? GLP-1 medications help regulate blood sugar and curb appetite, making it easier for users to say “no” to high-calorie, ultra-processed foods and stick with nutritious meals. Studies show that users are not only eating less, but also changing their food preferences—often losing interest in junk food altogether. This isn’t just about losing weight; it’s about transforming lifestyles and building habits that last.
If you’ve already joined our clinic, take pride in knowing your decision is backed by science and is powerful enough to shift national trends. And if you’re considering starting GLP-1 therapy, now is the perfect time. You’ll be supported by a team that’s on the cutting edge of medical weight loss—and you’ll be joining a movement that’s changing the way America eats.
Ready to start your journey? Book your consultation today and discover how GLP-1 medications can help you achieve your healthiest, happiest self!
Best regards,
Daryl, Jennifer, and the entire staff.
Pacific Northwest Medical Group
6622 112th ST E, Puyallup WA 98373
253-340-2270
Book a FREE consult now <- Click There!
Original Article: https://www.cbsnews.com/news/mcdonalds-downgrade-weight-loss-drugs/
